The Massachusetts Life Sciences Center (MLSC) and Dana-Farber Cancer Institute announced the official opening of Dana-Farber’s Molecular Cancer Imaging Facility in Boston’s Innovation District. The 50,000-square-foot, research center, supported by a grant from the Massachusetts Life Sciences Center, features Boston's first cyclotron dedicated solely to cancer research and is expected to allow Dana-Farber to advance drug discovery and accelerate the delivery of innovative therapies to patients.

Officials say the Center will deliver a comprehensive platform for determining drug efficacy within days, versus weeks or months, ultimately shortening the time it takes for new drugs to reach patients.








This site uses Akismet to reduce spam. Learn how your comment data is processed.